Tag: Biopharmaceutical company

press-release-alvotech-and-stada-add-to-strategic-alliance-through-denosumab-partnership

Press release: Alvotech and STADA add to strategic alliance through denosumab partnership

Alvotech and STADA have expanded their strategic alliance by partnering on AVT03, a biosimilar to Prolia® and Xgeva® (denosumab) for the treatment of osteoporosis...
newron-pharmaceuticals-will-host-its-2024-investor-day-on-june-25-in-new-york-city

Newron Pharmaceuticals Will Host Its 2024 Investor Day on June 25 in New York...

New Hope for Treatment-Resistant Schizophrenia Revealed at Newron Pharmaceuticals 2024 Investor DayNewron Pharmaceuticals S.p.A. announced its upcoming 2024 Investor Day on June 25, 2024,...

Top News

BREAKING NEWS